Results 221 to 230 of about 44,269 (308)

Esthetic and patient‐reported outcomes in immediate implants with adjunctive surgical procedures to increase soft tissue thickness/height: A systematic review

open access: yesPeriodontology 2000, EarlyView.
Abstract To explore the impact of soft tissue augmentation procedures during immediate implant placement (IIP) on clinician‐assessed esthetic outcomes and patient‐reported outcome measures (PROMs). A systematic literature search was conducted in PubMed, Cochrane Library, and Embase until March 2024.
France Lambert   +5 more
wiley   +1 more source

Bispecific Antibodies Versus Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Comparative Narrative Review of Efficacy, Safety, and Accessibility

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Introduction Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma, and despite advances in frontline therapies such as rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone, approximately 30%–40% of patients develop relapsed or refractory (
Dana Sofian Abou   +6 more
wiley   +1 more source

Basement membrane degeneration is common in lichenoid mucositis with dysplasia.

open access: green, 2021
Iris Lin   +5 more
openalex   +1 more source

Photobiomodulation and Radio‐Epithelitis in Anal Carcinoma: A Case‐Report and Clinical Reflection on Emerging Preventive and Supportive Care Modalities

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Radio‐induced dermatitis, a frequent adverse effect of radiation therapy, is particularly prevalent in patients treated for anal margin carcinoma. It may present with varying severity, causing significant pain and impairment of daily mobility, influenced by both patient‐related factors and treatment regimens.
Michèle Pelletier‐Aouizerate   +1 more
wiley   +1 more source

Retrospective analysis of cutaneous immune‐related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA‐B*51:01 allele

open access: yesCancer, Volume 132, Issue 3, 1 February 2026.
ABSTRACT Background While immune checkpoint inhibitors (ICIs) have shown significant efficacy, a common side effect is cutaneous immune‐related adverse events (irAEs). This study focuses on exploring the association between specific human leukocyte antigen (HLA) alleles and the development of cutaneous irAEs in melanoma patients undergoing ICI ...
Mckenzie DiLeo   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy